Abstract:Radiation‐recruited macrophages promote the proneural–mesenchymal transition process and result in radioresistance in glioblastoma. Rationally designed macrophage membrane‐coated porous mesoporous silica nanoparticles loaded therapeutic anti‐NF‐κB peptides can modulate the mesenchymal transformation and competitively inhibit the chemotaxis of peripheral macrophages into the brain for effectively improving radiotherapy response in glioblastoma. Radiotherapy is identified as a crucial treatment for patients with glioblastoma, but recurrence is inevitable. The efficacy of radiotherapy is severely hampered partially due to the tumor evolution. Growing evidence suggests that proneural glioma stem cells can acquire mesenchymal features coupled with increased radioresistance. Thus, a better understanding of mechanisms underlying tumor subclonal evolution may develop new strategies. Herein, data highlighting a positive correlation between the accumulation of macrophage in the glioblastoma microenvironment after irradiation and mesenchymal transdifferentiation in glioblastoma are presented. Mechanistically, elevated production of inflammatory cytokines released by macrophages promotes mesenchymal transition in an NF‐κB‐dependent manner. Hence, rationally designed macrophage membrane‐coated porous mesoporous silica nanoparticles (MMNs) in which therapeutic anti‐NF‐κB peptides are loaded for enhancing radiotherapy of glioblastoma are constructed. The combination of MMNs and fractionated irradiation results in the blockage of tumor evolution and therapy resistance in glioblastoma‐bearing mice. Intriguingly, the macrophage invasion across the blood‐brain barrier is inhibited competitively by MMNs, suggesting that these nanoparticles can fundamentally halt the evolution of radioresistant clones. Taken together, the biomimetic MMNs represent a promising strategy that prevents mesenchymal transition and improves therapeutic response to irradiation as well as overall survival in patients with glioblastoma.

Hijacked macrophages sustain glioblastoma cells

Macrophage-mediated myelin recycling fuels brain cancer malignancy

Lipid transfer from tumour-associated macrophages supports glioblastoma

Lipid-laden macrophages recycle myelin to feed glioblastoma

Macrophages/Microglia in the Glioblastoma Tumor Microenvironment

Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression

Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma

Lipid metabolic rewiring in glioma‑associated microglia/macrophages (Review)

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

Adoptive macrophages reverse the immunosuppressive microenvironment in glioblastoma via programmed phenotypic polarization

Protumoral lipid droplet–loaded macrophages are enriched in human glioblastoma and can be therapeutically targeted

Microglia and macrophages in glioblastoma: landscapes and treatment directions

Integrative single-cell and bulk transcriptome analyses identify a distinct pro-tumor macrophage signature that has a major prognostic impact on glioblastomas

Inside help for brain tumors: macrophage-mediated myelin recycling promotes cell state-specific glioblastoma progression

Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker

Spatially Resolved Microglia/Macrophages in Recurrent Glioblastomas Overexpress Fatty Acid Metabolism and Phagocytic Genes

Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma

FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells

Microglia and Brain Macrophages as Drivers of Glioma Progression

Feeding the wrath with myelin

Macrophage Membrane‐Coated Nanoparticles Sensitize Glioblastoma to Radiation by Suppressing Proneural–Mesenchymal Transformation in Glioma Stem Cells